Neurofibromatosis, Type I

Alternative Names

  • NF1
  • Neurofibromatosis
  • von Recklinghausen Disease
  • Neurofibromin
  • Neurofibromatosis, Type I with Leukemia
  • Neurofibromatosis, Type I with Glioma
  • NF1 Microdeletion Syndrome
  • NF1 Microduplication Syndrome

Associated Genes

Neurofibromin 1
Back to search Result
WHO-ICD-10 version:2010

Congenital malformations, deformations and chromosomal abnormalities

Other congenital malformations

OMIM Number

162200

Mode of Inheritance

Autosomal dominant

Gene Map Locus

17q11.2

Description

Neurofibromatosis type 1 (NF1) is one of the most common autosomal dominant disorders affecting 1 in 3500 people. NF1 is a complex neurocutaneous disorder with an increased susceptibility to develop both benign and malignant tumors but with a wide spectrum of inter and intrafamilial clinical variability. The most prominent clinical hallmarks of the disorder are café-au-lait macules, neurofibromas, Lisch nodules of the iris, and axillary freckling. Other clinical manifestations are abnormalities of the cardiovascular, gastrointestinal, renal, and endocrine systems, facial and body disfigurement, cognitive deficit, and malignancies of the peripheral nerve sheath and central nervous system. About 25% of people with neurofibromatosis type 1 develop one or more of these clinical complications, which together cause significant morbidity and mortality. The tumors that occur in neurofibromatosis type 1 are dermal and plexiform neurofibromas, optic gliomas, malignant peripheral nerve sheath tumors, pheochromocytomas, and rhabdomyosarcomas. Children with neurofibromatosis type 1 have an increased risk of developing myeloid disease, particularly juvenile chronic myeloid leukemia.

Neurofibromatosis type I is caused by mutation in the neurofibromin gene, NF1.

Epidemiology in the Arab World

View Map
Subject IDCountrySexFamily HistoryParental ConsanguinityHPO TermsVariantZygosityMode of InheritanceReferenceRemarks
162200.1LebanonMaleYes Cafe-au-lait spot; Soft skin; Abnormal...NM_001042492.2:c.1019_1020delHeterozygousAutosomal, DominantNair et al. 2018
162200.2Lebanon Multiple cafe-au-lait spotsNM_001042492.2:c.495_498delTGTTHeterozygousAutosomal, DominantNair et al. 2018
162200.3United Arab EmiratesFemaleNoNo Multiple cafe-au-lait spots; Plexiform ...NM_001042492.3:c.1062+2T>CHeterozygousAutosomal, DominantBen-Salem et al. 2014
162200.4United Arab EmiratesFemaleNoNo Multiple cafe-au-lait spots; Inguinal f...NM_001042492.3:c.3291delHeterozygousAutosomal, DominantBen-Salem et al. 2014
162200.5United Arab EmiratesMaleNoNo Multiple cafe-au-lait spots; Plexiform ...NM_001042492.3:c.5347delHeterozygousAutosomal, DominantBen-Salem et al. 2014
162200.6United Arab EmiratesMaleNoNo Cafe-au-lait spot; Lisch nodulesNM_001042492.3:c.2540T>CHeterozygousAutosomal, DominantBen-Salem et al. 2014
162200.7United Arab EmiratesMaleNoNo Cafe-au-lait spot; Axillary freckling;...NM_001042492.3:c.6546C>GHeterozygousAutosomal, DominantBen-Salem et al. 2014
162200.8United Arab EmiratesMaleNoNo Cafe-au-lait spotNM_001042492.3:c.4065_4066delHeterozygousAutosomal, DominantBen-Salem et al. 2014
162200.9.1United Arab EmiratesFemaleYesYes Cafe-au-lait spotNM_001042492.2:c.1846delHeterozygousAutosomal, DominantBen-Salem et al. 2014 Proband
162200.9.2United Arab EmiratesFemaleYesYes Cafe-au-lait spotNM_001042492.2:c.1846delHeterozygousAutosomal, DominantBen-Salem et al. 2014 Sister of 162200.9.1
162200.9.3United Arab EmiratesFemaleYesYes Cafe-au-lait spotNM_001042492.2:c.1846delHeterozygousAutosomal, DominantBen-Salem et al. 2014 Mother of 162200.9.1
162200.10.1United Arab EmiratesMaleYesNo Cafe-au-lait spotNM_001042492.3:c.6374T>CHeterozygousAutosomal, DominantBen-Salem et al. 2014
162200.10.2United Arab EmiratesMaleYesNo Cafe-au-lait spot; NeurofibromasNM_001042492.3:c.6374T>CHeterozygousAutosomal, DominantBen-Salem et al. 2014 Father of 162200.10....
162200.11IraqUnknown NeurofibromasNM_001042492.2:c.7380delHeterozygousAutosomal, DominantAl-Gazali and Ali, 2010
162200.12LebanonUnknownYes Neurofibromas; Imbalanced hemoglobin syn...NM_001042492.3:c.7317dupHeterozygousAutosomal, DominantJalkh et al. 2019
162200.13United Arab EmiratesFemaleNoNo Specific learning disability; Multiple c...NM_000267.3:c.1397_1398dupHeterozygousSaleh et al. 2021 de novo mutation
162200.15United Arab EmiratesMaleYesNo Specific learning disability; Attention ...NM_000267.3:c.1317delHeterozygousAutosomal, DominantSaleh et al. 2021 Affected father and ...
162200.16United Arab EmiratesMaleNoYes Specific learning disability; Diminished...NM_000267.3:c.574C>THeterozygousSaleh et al. 2021 de novo mutation
162200.17United Arab EmiratesMaleNoNo Seizure; Global developmental delay; Hyp...NM_001042492.3:c.6733C>THeterozygousSaleh et al. 2021 de novo mutation
162200.18United Arab EmiratesFemaleNoNo Multiple cafe-au-lait spots; Myopia; Spe...NM_001042492.3:c.6374T>CHeterozygousAutosomal, DominantSaleh et al. 2021 Affected father
162200.19Saudi ArabiaMaleYesYes Multiple cafe-au-lait spots; Axillary fr...NM_001042492.3:c.3721C>THeterozygousAutosomal, DominantMaddirevula et al. 2018 De novo mutation
162200.20.1Saudi ArabiaMaleYes Multiple cafe-au-lait spots; Axillary fr...NM_001042492.3:c.2998_2999delHeterozygousAutosomal, DominantMaddirevula et al. 2018 Patient's parents ar...
162200.20.2Saudi ArabiaMaleYes Multiple cafe-au-lait spots; Axillary fr...NM_001042492.3:c.2998_2999delHeterozygousAutosomal, DominantMaddirevula et al. 2018 Relative of 162200.2...
162200.21Saudi ArabiaFemale Multiple cafe-au-lait spots; Axillary fr...NM_001042492.3:c.6704+2T>GHeterozygousAutosomal, DominantMaddirevula et al. 2018 De novo mutation; Pa...
162200.22Saudi ArabiaMaleYes Multiple cafe-au-lait spots; Axillary fr...NM_001042492.3:c.3129delHeterozygousAutosomal, DominantMaddirevula et al. 2018 De novo mutation
162200.23.1Saudi ArabiaMaleYes Multiple cafe-au-lait spots; Axillary fr...NM_001042492.3:c.5529dupHeterozygousAutosomal, DominantMaddirevula et al. 2018 Patient's parents ar...
162200.23.2Saudi ArabiaMaleYes Multiple cafe-au-lait spots; Axillary fr...NM_001042492.3:c.5529dupHeterozygousAutosomal, DominantMaddirevula et al. 2018 Relative of 162200.2...
162200.23.3Saudi ArabiaFemaleYes Multiple cafe-au-lait spots; Axillary fr...NM_001042492.3:c.5529dupHeterozygousAutosomal, DominantMaddirevula et al. 2018 Relative of 162200.2...
162200.24SyriaMaleNo Global developmental delay; Multiple caf...NM_001042492.3:c.3574G>THeterozygousAutosomal, DominantMaddirevula et al. 2018 De novo mutation
162200.25.1Saudi ArabiaFemaleYesNo Optic nerve glioma; Short stature; Relat...NM_001042492.3:c.775delHeterozygousAutosomal, DominantMaddirevula et al. 2018
162200.25.2Saudi ArabiaMaleYesNo Optic nerve glioma; Short stature; Relat...NM_001042492.3:c.775delHeterozygousAutosomal, DominantMaddirevula et al. 2018 Relative of 162200.2...
162200.25.3Saudi ArabiaFemaleYesNo Optic nerve glioma; Short stature; Relat...NM_001042492.3:c.775delHeterozygousAutosomal, DominantMaddirevula et al. 2018 Relative of 162200.2...

Other Reports

Arab

Mandani et al. (1996) reported the case of a boy aged just over five years with neurofibromatosis type 1, who developed precocious puberty at the age of four years. The latter disorder appeared to have a CNS origin.

[Mandani F, Al Tawari A, Al Mazidi Z. Precocious puberty in a child with neurofibromatosis. Kuwait Med J. 1996; 28(2):209-11.]

Kuwait

Nanda (2008) described two patients of neurofibromatosis type 1 having an association with vitiligo in one, and alopecia areata and autoimmune thyroiditis in another.

Morocco

Tarrass (2008) described a patient with an association of Neurofibromatosis Type I with Focal and Segmental Glomerulosclerosis. The 58-year-old male patient with known NF1 presented with deteriorating renal function. He had no family history of NF or kidney disease. Upon examination, he was found to be hypertensive, and had café au lait spots and multiple neurofibromas scattered all across his chest, back, and arms. Serum creatinine was high at 6.5 mg/dl, and urinalysis showed proteinuria of 4 g/day, with microscopic hematuria. Renal biopsy revealed FSGS with severe interstitial fibrosis and tubular atrophy. Tarrass (2008) suggested linkage investigation to assess whether the co-occurrence of these two evidences was coincidental or linked to the same gene defect.

Oman

Jacob and Chand (1995) reported massive cerebral infarction in an Omani man aged 32-years with neurofibromatosis type 1. This patient was not known to be hypertensive or diabetic and was not a smoker. He was brought to the emergency with one day history of altered consciousness and left sided weakness. Clinically, he was found to have high blood pressure of 170/125 mmHg, although his cardiovascular system was normal. He was noticed to have multiple skin lesions (measured 2cm by 3cm) of café au lait spots and freckles all over his chest, abdomen and hips, as well as soft subcutaneous neurofibromas on the extremities and trunk, and osteoma on the sternum. Neurologically, he was drowsy, inattentive, obeying simple commands, had dense left hemiplegia and hemianesthesia, but there were no signs of meningeal irritation. Investigations revealed evidence of renal failure with elevation of blood urea and serum creatinine, normal blood counts, and normal blood biochemistry. Chest x-ray was normal, but abdominal ultrasound revealed a small right kidney (hypoplastic or ischemic). CT scan of the brain showed extensive infarction due to internal carotid artery occlusion which manifested as large non-enhancing hypodense areas on the right frontal, temperol and occipital lobes. Other investigations were planned (carotid Doppler studies, echocardiogram and carotid angiogram) but the patient's condition deteriorated and he became unresponsive and then died. The patient's family refused autopsy. Jacob and Chand (1995) concluded by mentioning that neurofibromatosis could cause cerebral infarction in the young.

Koul et al. (2000) reported the diagnosis of neurofibromatosis type 1 in monozygotic twins with Dandy-Walker syndrome. The twins, both males, were born at term vaginally to non-consanguineous parents and at delivery they were noted to be monozygotic twins as there was a single placenta. There were no antenatal or perinatal complications. As motor and mental developmental delay was noticed by the parents, these children at the age of 32-months were referred to the authors' care for neurological evaluation, which revealed marked motor delay (head control at nine months, sitting at one year, and just standing with support when seen) and no speech development. Examination revealed head circumference at the 50th percentile but both weight and height were below the third percentile. Both children had dysmorphic features which were not descriptive of any syndrome, including prominent forehead, hypotelorism, low set ears and prominent occiput. In addition to these features, they had café-au-lait spots seen more on their trunks with few of 5 cm2 in size, along with few depigmented spots. A diagnosis of neurofibromatosis type 1 was made on the bass of the presence of the features of café-au-lait, microcephaly and short stature. Routine investigations, including blood count, liver and renal function tests, nerve conduction studies and brainstem auditory evoked potential, and karyotyping were normal. In both children, CT scan of the brain revealed typical features of Dandy-Walker syndrome which were cerebellar aplasia, cystic dilatation of the fourth ventricle and enlarged posterior fossa. In addition, one twin had hydrocephalus as well. Koul et al. (2000) suggested an underlying genetic basis for this unique association of neurofibromatosis type 1 with Dandy-Walker syndrome in monozygotic twins.

Saudi Arabia

Alorainy (2006) reviewed and analyzed the MRI studies on 808 pediatric patients (aged 3 days to 15 years) over a 3-year period.  A total of 114 congenital cerebral malformations were identified in 86 of these patients via MRI.  Nine patients were identified with neurofibromatosis.

Bin Amer and Al-Khenaizan (2007) described a patient with Neurofibromatosis in association with malignant melanoma. The 21-month old Saudi boy presented with fever, cough, respiratory distress, and progressive bone pain in the right leg. He was found to have hepatosplenomegaly, and decreased air entry with coarse crepitations. CT chest showed large opacities in both lungs. There was severe tenderness over the right femur, and CT showed bone destruction in the proximal right femur. The patient had major pigmentary changes on the skin; multiple café-au-lait macules on the trunk and extremities, skin-colored firm neurofibromas on the back, and a giant speckled lentiginous nevus extending from the waist to mid-thighs studded with multiple hairy giant congenital melanocytic nevi. Biopsy results of the skin and bone were consistent with a diagnosis of invasive malignant melanoma. A week after the diagnosis, the patient died of respiratory failure.

Tunisia

Gouider et al. (1994) conducted a multidisciplinary transversal descriptive study (June-October 1992) to determine the clinical manifestations and laboratory findings observed in 66 patients from Tunisia with type 1 neurofibromatosis. All patients over the age of 25 had café-au-lait spots, neurofibromas, lentigines and nodules. Occurrence of lesions of the central nervous system was significantly earlier than peripheral nervous manifestations. The optic glioma was the most frequent lesion of the central nervous system. Complications were observed during the first twenty years of the disease.

United Arab Emirates

Ben-Salem et al. (2014) identified a large novel 9.2 kb deletion in the NF1 gene of three members of an Emirati family. 

© CAGS 2024. All rights reserved.